Header Logo

Connection

KALPALATHA GUNTUPALLI to Recombinant Proteins

Back to Details
This is a "connection" page, showing publications KALPALATHA GUNTUPALLI has written about Recombinant Proteins.
KALPALATHA GUNTUPALLI
Connection Strength
0.077
Recombinant Proteins
  1. A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis. Crit Care Med. 2013 Mar; 41(3):706-16.
    View in: PubMed
    Score: 0.077
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.